Esophageal Cancer Clinical Trials in L'Hospitalet de Llobregat, Barcelona

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors